Immunohistochemical determination of hormone receptors in uterine adenosarcomas

Gynecologic Oncology

Volumn 88, Issue 3, 2003, Pages 463-464

  Amant, Frédéric ^a   Gabriel, Charlotte ^a   Moerman, Philippe ^a   Vergote, Ignace ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN RECEPTOR; GONADORELIN DERIVATIVE; HORMONE; PROGESTERONE; PROGESTERONE RECEPTOR;

ADVANCED CANCER; CANCER SURVIVAL; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM SARCOMA; HORMONAL THERAPY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MATERNAL AGE; OVARIECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; RECURRENT DISEASE; TREATMENT CONTRAINDICATION; UTERINE ADENOSARCOMA; UTERUS CARCINOMA;

EID: 0037342864     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(02)00006-9     Document Type: Letter

References (4)

1. Michener C.M., Simon N.L. Ovarian conservation in a woman of reproductive age with Müllerian adenosarcoma. Gynecol Oncol. 83:2001;424-427.
2. Clement P., Scully R. Mullerian adenosarcoma of the uterus a clinicopathologic analysis of 100 cases with a review of the literature . Hum Pathol. 21:1990;363-381.
3. Krivak T., Seidman J., McBroom J., MacKoul P., Aye L., Rose G. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma comparison of treatment and survival . Gynecol Oncol. 83:2001;89-94.
4. Maluf F., Sabbatini P., Schwartz L., Xia J., Aghajanian C. Endometrial stromal sarcoma objective response to letrozole . Gynecol Oncol. 82:2001;384-388.